Skip to main content

Find Clinical Trials

Home
Conditions
Extensive-stage Small Cell Lung Cancer (SCLC)

Clinical trial condition

Extensive-stage Small Cell Lung Cancer (SCLC)

Explore clinical trials studying Extensive-stage Small Cell Lung Cancer (SCLC). Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Extensive-stage Small Cell Lung Cancer (SCLC) trial results

Enrolling by Invitation

YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

NCT07390565

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (SCLC), +8 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing, Chaoyang, China

View Trial Details

Not Yet Recruiting

Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer

NCT07106528

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +10 more
Locations: Not specified

View Trial Details

Completed

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

NCT02312622

Conditions: Brain Diseases, Brain Neoplasms, Breast Diseases, +24 more
Locations: Stanford University, School of Medicine Stanford, California, United States

View Trial Details